U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.3982T>G (p.Ser1328Ala) AND Early infantile epileptic encephalopathy with suppression bursts

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 25, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002889282.3

Allele description [Variation Report for NM_001165963.4(SCN1A):c.3982T>G (p.Ser1328Ala)]

NM_001165963.4(SCN1A):c.3982T>G (p.Ser1328Ala)

Genes:
SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
LOC102724058:uncharacterized LOC102724058 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.3982T>G (p.Ser1328Ala)
HGVS:
  • NC_000002.12:g.166009739A>C
  • NG_011906.1:g.68901T>G
  • NM_001165963.4:c.3982T>GMANE SELECT
  • NM_001165964.3:c.3898T>G
  • NM_001202435.3:c.3982T>G
  • NM_001353948.2:c.3982T>G
  • NM_001353949.2:c.3949T>G
  • NM_001353950.2:c.3949T>G
  • NM_001353951.2:c.3949T>G
  • NM_001353952.2:c.3949T>G
  • NM_001353954.2:c.3946T>G
  • NM_001353955.2:c.3946T>G
  • NM_001353957.2:c.3898T>G
  • NM_001353958.2:c.3898T>G
  • NM_001353960.2:c.3895T>G
  • NM_001353961.2:c.1540T>G
  • NM_006920.6:c.3949T>G
  • NP_001159435.1:p.Ser1328Ala
  • NP_001159436.1:p.Ser1300Ala
  • NP_001189364.1:p.Ser1328Ala
  • NP_001340877.1:p.Ser1328Ala
  • NP_001340878.1:p.Ser1317Ala
  • NP_001340879.1:p.Ser1317Ala
  • NP_001340880.1:p.Ser1317Ala
  • NP_001340881.1:p.Ser1317Ala
  • NP_001340883.1:p.Ser1316Ala
  • NP_001340884.1:p.Ser1316Ala
  • NP_001340886.1:p.Ser1300Ala
  • NP_001340887.1:p.Ser1300Ala
  • NP_001340889.1:p.Ser1299Ala
  • NP_001340890.1:p.Ser514Ala
  • NP_008851.3:p.Ser1317Ala
  • NP_008851.3:p.Ser1317Ala
  • LRG_8t1:c.3949T>G
  • LRG_8:g.68901T>G
  • LRG_8p1:p.Ser1317Ala
  • NC_000002.11:g.166866249A>C
  • NM_006920.4:c.3949T>G
  • NR_148667.2:n.4335T>G
Protein change:
S1299A
Molecular consequence:
  • NM_001165963.4:c.3982T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.3898T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.3982T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.3982T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.3949T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.3949T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.3949T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.3949T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.3946T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.3946T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.3898T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.3898T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.3895T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353961.2:c.1540T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.3949T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.4335T>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Early infantile epileptic encephalopathy with suppression bursts (EIEE)
Synonyms:
Early infantile epileptic encephalopathy; Ohtahara syndrome; Developmental and epileptic encephalopathy
Identifiers:
MONDO: MONDO:0100062; MedGen: C0393706; Orphanet: 1934; OMIM: PS308350

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003233220Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Oct 25, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients.

Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, Keren B, Abert B, Gautier A, Baulac S, Arzimanoglou A, Cazeneuve C, Nabbout R, LeGuern E.

J Med Genet. 2009 Mar;46(3):183-91. doi: 10.1136/jmg.2008.062323. Epub 2008 Oct 17.

PubMed [citation]
PMID:
18930999

Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.

Wang JW, Shi XY, Kurahashi H, Hwang SK, Ishii A, Higurashi N, Kaneko S, Hirose S; Epilepsy Genetic Study Group Japan..

Epilepsy Res. 2012 Dec;102(3):195-200. doi: 10.1016/j.eplepsyres.2012.06.006. Epub 2012 Jul 20.

PubMed [citation]
PMID:
23195492
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003233220.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant disrupts the p.Ser1328 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18930999, 23195492, 27458797, 29573403). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function. This variant has not been reported in the literature in individuals affected with SCN1A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 1328 of the SCN1A protein (p.Ser1328Ala). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024